Neurana Pharmaceuticals is a privately-held, clinical stage specialty pharmaceutical company developing tolperisone, a novel non-opioid drug for acute muscle spasms.

Tolperisone has been approved in Europe and Asia, and has been shown to be an effective treatment for muscle spasms and spasticity. Clinical studies and commercial usage have shown that tolperisone is safe and efficacious, and that the drug is non-sedating and non-addictive.

For more information visit: https://neuranapharma.com/